Maternal TDF and FTC to Reduce NNRTI Resistance Mutations After Intrapartum NVP

Update Il y a 4 ans
Reference: NCT00204308

Woman Man

  • | Country :
  • Zambia
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The purpose of this study is to determine whether the addition of tenofovir (TDF) and emtricitabine (FTC)to a standard PMTCT regimen containing single-dose nevirapine (NVP) can reduce the development of post-ingestion HIV resistance to non-nucleoside reverse transcriptase inhibitors (NNRTIs).


Inclusion criteria

  • HIV ,pregnancy

Links